PTC Therapeutics, Inc.
Treatment of pervasive developmental disorders with redox-active therapeutics
Last updated:
Abstract:
Methods of treating or suppressing pervasive developmental disorders (PDDs) including; autistic disorder, Asperger's syndrome, childhood disintegrative disorder (CDD), Rett's disorder, and PDD-not otherwise specified (PDD-NOS) or attention deficit/hyperactivity disorder (ADHD) comprising administering to a subject in need thereof a therapeutically effective amount of one or more compounds as disclosed herein.
Status:
Grant
Type:
Utility
Filling date:
19 Oct 2018
Issue date:
11 Aug 2020